{"parse":{"title":"Consolidated Standards of Reporting Trials","pageid":11087233,"revid":857916633,"text":{"*":"<div class=\"mw-parser-output\"><p><b>CONSORT</b> (<b>Consolidated Standards Of Reporting Trials</b>) encompasses various initiatives developed by the CONSORT Group to alleviate the problems arising from inadequate reporting of <a href=\"/wiki/Randomized_controlled_trial\" title=\"Randomized controlled trial\">randomized controlled trials</a>.\n</p>\n<div id=\"toc\" class=\"toc\"><input type=\"checkbox\" role=\"button\" id=\"toctogglecheckbox\" class=\"toctogglecheckbox\" style=\"display:none\" /><div class=\"toctitle\" lang=\"en\" dir=\"ltr\"><h2>Contents</h2><span class=\"toctogglespan\"><label class=\"toctogglelabel\" for=\"toctogglecheckbox\"></label></span></div>\n<ul>\n<li class=\"toclevel-1 tocsection-1\"><a href=\"#The_CONSORT_Statement\"><span class=\"tocnumber\">1</span> <span class=\"toctext\">The CONSORT Statement</span></a>\n<ul>\n<li class=\"toclevel-2 tocsection-2\"><a href=\"#Extensions_of_the_CONSORT_Statement\"><span class=\"tocnumber\">1.1</span> <span class=\"toctext\">Extensions of the CONSORT Statement</span></a></li>\n</ul>\n</li>\n<li class=\"toclevel-1 tocsection-3\"><a href=\"#History\"><span class=\"tocnumber\">2</span> <span class=\"toctext\">History</span></a></li>\n<li class=\"toclevel-1 tocsection-4\"><a href=\"#Impact\"><span class=\"tocnumber\">3</span> <span class=\"toctext\">Impact</span></a></li>\n<li class=\"toclevel-1 tocsection-5\"><a href=\"#See_also\"><span class=\"tocnumber\">4</span> <span class=\"toctext\">See also</span></a></li>\n<li class=\"toclevel-1 tocsection-6\"><a href=\"#References\"><span class=\"tocnumber\">5</span> <span class=\"toctext\">References</span></a></li>\n</ul>\n</div>\n\n<h2><span class=\"mw-headline\" id=\"The_CONSORT_Statement\">The CONSORT Statement</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Consolidated_Standards_of_Reporting_Trials&amp;action=edit&amp;section=1\" title=\"Edit section: The CONSORT Statement\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>The main product of the CONSORT Group is the CONSORT Statement,<sup id=\"cite_ref-statement_1-0\" class=\"reference\"><a href=\"#cite_note-statement-1\">&#91;1&#93;</a></sup> which is an <a href=\"/wiki/Evidence-based_medicine\" title=\"Evidence-based medicine\">evidence-based</a>, minimum set of recommendations for reporting <a href=\"/wiki/Clinical_trial#Design\" title=\"Clinical trial\">randomized trials</a>. It offers a standard way for authors to prepare reports of trial findings, facilitating their complete and transparent reporting, reducing the influence of bias on their results, and aiding their critical appraisal and interpretation.\n</p><p>The most recent version of the Statement&#8212;the CONSORT 2010 Statement&#8212;consists of a 25-item <a href=\"/wiki/Checklist\" title=\"Checklist\">checklist</a> and a participant flow diagram, along with some brief descriptive text. The checklist items focus on reporting how the trial was designed, analyzed, and interpreted; the flow diagram displays the progress of all participants through the trial. The Statement has been translated into several languages.\n</p><p>The CONSORT \u2018Explanation and Elaboration\u2019 document<sup id=\"cite_ref-explain_2-0\" class=\"reference\"><a href=\"#cite_note-explain-2\">&#91;2&#93;</a></sup> explains and illustrates the principles underlying the CONSORT Statement. It is strongly recommended that it is used in conjunction with the CONSORT Statement.<sup id=\"cite_ref-statement_1-1\" class=\"reference\"><a href=\"#cite_note-statement-1\">&#91;1&#93;</a></sup>\n</p><p>Considered an evolving document,<sup id=\"cite_ref-explain_2-1\" class=\"reference\"><a href=\"#cite_note-explain-2\">&#91;2&#93;</a></sup> the CONSORT Statement is subject to periodic changes as new evidence emerges; the most recent update was published in March 2010. The current definitive version of the CONSORT Statement and up-to-date information on extensions are placed on  the CONSORT website.\n</p>\n<h3><span class=\"mw-headline\" id=\"Extensions_of_the_CONSORT_Statement\">Extensions of the CONSORT Statement</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Consolidated_Standards_of_Reporting_Trials&amp;action=edit&amp;section=2\" title=\"Edit section: Extensions of the CONSORT Statement\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>The main CONSORT Statement is based on the 'standard' two-group parallel design. Extensions of the CONSORT Statement have been developed to give additional guidance for randomized trials with specific designs (e.g., <a href=\"/wiki/Cluster_randomized_trial\" class=\"mw-redirect\" title=\"Cluster randomized trial\">cluster randomized trials</a>,<sup id=\"cite_ref-3\" class=\"reference\"><a href=\"#cite_note-3\">&#91;3&#93;</a></sup> noninferiority and equivalence trials,<sup id=\"cite_ref-4\" class=\"reference\"><a href=\"#cite_note-4\">&#91;4&#93;</a></sup> pragmatic trials,<sup id=\"cite_ref-5\" class=\"reference\"><a href=\"#cite_note-5\">&#91;5&#93;</a></sup>), data (e.g., harms,<sup id=\"cite_ref-6\" class=\"reference\"><a href=\"#cite_note-6\">&#91;6&#93;</a></sup> <a href=\"/wiki/Abstract_(summary)\" title=\"Abstract (summary)\">abstracts</a><sup id=\"cite_ref-7\" class=\"reference\"><a href=\"#cite_note-7\">&#91;7&#93;</a></sup>), and interventions (e.g., <a href=\"/wiki/Herbalism\" title=\"Herbalism\">herbals</a>,<sup id=\"cite_ref-8\" class=\"reference\"><a href=\"#cite_note-8\">&#91;8&#93;</a></sup>  non-pharmacologic treatments,<sup id=\"cite_ref-9\" class=\"reference\"><a href=\"#cite_note-9\">&#91;9&#93;</a></sup> <a href=\"/wiki/Acupuncture\" title=\"Acupuncture\">acupuncture</a><sup id=\"cite_ref-10\" class=\"reference\"><a href=\"#cite_note-10\">&#91;10&#93;</a></sup>). This list is, by no means, exhaustive, and work is ongoing.\n</p>\n<h2><span class=\"mw-headline\" id=\"History\">History</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Consolidated_Standards_of_Reporting_Trials&amp;action=edit&amp;section=3\" title=\"Edit section: History\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>In 1993, 30 experts - <a href=\"/wiki/Medical_journal\" title=\"Medical journal\">medical journal</a> editors, clinical trialists, <a href=\"/wiki/Epidemiology\" title=\"Epidemiology\">epidemiologists</a>, and <a href=\"/wiki/Methodology\" title=\"Methodology\">methodologists</a> - met in <a href=\"/wiki/Ottawa\" title=\"Ottawa\">Ottawa, Canada</a> to discuss ways of improving the reporting of randomized trials. This meeting resulted in the Standardized Reporting of Trials (SORT) statement,<sup id=\"cite_ref-11\" class=\"reference\"><a href=\"#cite_note-11\">&#91;11&#93;</a></sup> a 32-item checklist and flow diagram in which investigators were encouraged to report on how randomized trials were conducted.\n</p><p>Concurrently, and independently, another group of experts, the Asilomar Working Group on Recommendations for Reporting of Clinical Trials in the Biomedical Literature, convened in <a href=\"/wiki/California\" title=\"California\">California, USA</a>, and were working on a similar mandate. This group also published recommendations for authors reporting randomized trials.<sup id=\"cite_ref-12\" class=\"reference\"><a href=\"#cite_note-12\">&#91;12&#93;</a></sup>\n</p><p>At the suggestion of Dr. Drummond Rennie, from <a href=\"/wiki/Journal_of_the_American_Medical_Association\" class=\"mw-redirect\" title=\"Journal of the American Medical Association\">JAMA</a>,<sup id=\"cite_ref-13\" class=\"reference\"><a href=\"#cite_note-13\">&#91;13&#93;</a></sup> in 1995 representatives from both these groups met in <a href=\"/wiki/Chicago\" title=\"Chicago\">Chicago, USA</a>, with the aim of merging the best of the SORT and Asilomar proposals into a single, coherent evidence-based recommendation. This resulted in the Consolidated Standards of Reporting Trials (CONSORT) Statement, which was first published in 1996.<sup id=\"cite_ref-14\" class=\"reference\"><a href=\"#cite_note-14\">&#91;14&#93;</a></sup>  Further meetings of the CONSORT Group in 1999 and 2000 led to the publication of the revised CONSORT Statement in 2001.<sup id=\"cite_ref-15\" class=\"reference\"><a href=\"#cite_note-15\">&#91;15&#93;</a></sup>\n</p><p>Since the revision in 2001, the evidence base to inform CONSORT has grown considerably; empirical data highlighting new concerns regarding the reporting of randomized trials. Therefore, a third CONSORT Group meeting was held in 2007 resulting in publication of a newly revised CONSORT Statement<sup id=\"cite_ref-statement_1-2\" class=\"reference\"><a href=\"#cite_note-statement-1\">&#91;1&#93;</a></sup> and explanatory document<sup id=\"cite_ref-explain_2-2\" class=\"reference\"><a href=\"#cite_note-explain-2\">&#91;2&#93;</a></sup> in 2010. Users of the guideline are strongly recommended to refer to the most up-to-date version while writing or interpreting reports of clinical trials.\n</p>\n<h2><span class=\"mw-headline\" id=\"Impact\">Impact</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Consolidated_Standards_of_Reporting_Trials&amp;action=edit&amp;section=4\" title=\"Edit section: Impact\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>The CONSORT Statement has gained considerable support since its inception in 1996. Over 600 journals and editorial groups worldwide now endorse it, including <a href=\"/wiki/The_Lancet\" title=\"The Lancet\">The Lancet</a>, <a href=\"/wiki/British_Medical_Journal\" class=\"mw-redirect\" title=\"British Medical Journal\">BMJ</a>, <a href=\"/wiki/Journal_of_the_American_Medical_Association\" class=\"mw-redirect\" title=\"Journal of the American Medical Association\">JAMA</a>, <a href=\"/wiki/New_England_Journal_of_Medicine\" class=\"mw-redirect\" title=\"New England Journal of Medicine\">New England Journal of Medicine</a>, World Association of Medical Editors, and <a href=\"/wiki/Uniform_Requirements_for_Manuscripts_Submitted_to_Biomedical_Journals#International_Committee_of_Medical_Journal_Editors\" class=\"mw-redirect\" title=\"Uniform Requirements for Manuscripts Submitted to Biomedical Journals\">International Committee of Medical Journal Editors</a>. The 2001 revised Statement has been cited over 1,200 times and the accompanying explanatory document over 500 times. Another indication of CONSORT\u2019s impact is reflected in the approximately 17,500 hits per month that the CONSORT website has received. It has also recently been published as a book for those involved in the planning, conducting and interpretation of clinical trials.<sup id=\"cite_ref-16\" class=\"reference\"><a href=\"#cite_note-16\">&#91;16&#93;</a></sup>\n</p><p>Results from a recent <a href=\"/wiki/Systematic_review\" title=\"Systematic review\">systematic review</a> suggest that use of the CONSORT checklist is associated with improved reporting of randomized trials.<sup id=\"cite_ref-17\" class=\"reference\"><a href=\"#cite_note-17\">&#91;17&#93;</a></sup>\n</p><p>Similar initiatives to improve the reporting of other types of research have arisen after the introduction of CONSORT. They include: Strengthening the Reporting of Observational Studies in Epidemiology (STROBE),<sup id=\"cite_ref-18\" class=\"reference\"><a href=\"#cite_note-18\">&#91;18&#93;</a></sup> Standards for the Reporting of Diagnostic Accuracy Studies (STARD),<sup id=\"cite_ref-19\" class=\"reference\"><a href=\"#cite_note-19\">&#91;19&#93;</a></sup> Strengthening the Reporting of Genetic Association studies (STREGA),<sup id=\"cite_ref-20\" class=\"reference\"><a href=\"#cite_note-20\">&#91;20&#93;</a></sup> <a href=\"/wiki/Preferred_Reporting_Items_for_Systematic_Reviews_and_Meta-Analyses\" title=\"Preferred Reporting Items for Systematic Reviews and Meta-Analyses\">Preferred Reporting Items for Systematic Reviews and Meta-Analyses</a> (PRISMA),<sup id=\"cite_ref-21\" class=\"reference\"><a href=\"#cite_note-21\">&#91;21&#93;</a></sup> Standards for Quality Improvement Reporting Excellence (SQUIRE),<sup id=\"cite_ref-22\" class=\"reference\"><a href=\"#cite_note-22\">&#91;22&#93;</a></sup> among others. These reporting guidelines have been incorporated into the <a href=\"/wiki/EQUATOR_Network\" title=\"EQUATOR Network\">EQUATOR Network</a> initiative to enhance the transparent and accurate reporting of research studies.<sup id=\"cite_ref-23\" class=\"reference\"><a href=\"#cite_note-23\">&#91;23&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"See_also\">See also</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Consolidated_Standards_of_Reporting_Trials&amp;action=edit&amp;section=5\" title=\"Edit section: See also\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<ul><li><a href=\"/wiki/Strengthening_the_reporting_of_observational_studies_in_epidemiology\" title=\"Strengthening the reporting of observational studies in epidemiology\">STROBE</a></li></ul>\n<h2><span class=\"mw-headline\" id=\"References\">References</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Consolidated_Standards_of_Reporting_Trials&amp;action=edit&amp;section=6\" title=\"Edit section: References\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<div class=\"reflist\" style=\"list-style-type: decimal;\">\n<div class=\"mw-references-wrap mw-references-columns\"><ol class=\"references\">\n<li id=\"cite_note-statement-1\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-statement_1-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-statement_1-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-statement_1-2\"><sup><i><b>c</b></i></sup></a></span> <span class=\"reference-text\">Schulz KF, Altman DG, Moher D; CONSORT Group. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMJ. 2010 Mar23;340:c332</span>\n</li>\n<li id=\"cite_note-explain-2\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-explain_2-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-explain_2-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-explain_2-2\"><sup><i><b>c</b></i></sup></a></span> <span class=\"reference-text\">Moher D, Hopewell S, Schulz KF, Montori V, G\u00f8tzsche PC, Devereaux PJ, Elbourne D, Egger M, Altman DG. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. BMJ. 2010;340:c869</span>\n</li>\n<li id=\"cite_note-3\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-3\">^</a></b></span> <span class=\"reference-text\">Campbell MK, Elbourne DR, Altman DG. CONSORT statement: extension to cluster randomised trials. BMJ 2004; 328(7441):702-708. <a rel=\"nofollow\" class=\"external autonumber\" href=\"http://www.consort-statement.org/mod_product/uploads/CONSORT%20Extension%20for%20Cluster%20Trials%202004.pdf\">[1]</a></span>\n</li>\n<li id=\"cite_note-4\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-4\">^</a></b></span> <span class=\"reference-text\">Piaggio G, Elbourne DR, <a href=\"/wiki/Doug_Altman\" title=\"Doug Altman\">Altman DG</a>, <a href=\"/wiki/Stuart_Pocock\" title=\"Stuart Pocock\">Pocock SJ</a>, Evans SJW. Reporting of noninferiority and equivalence randomized trials: An extension of the CONSORT statement. JAMA 2006; 295:1152-1160. <a rel=\"nofollow\" class=\"external autonumber\" href=\"http://www.consort-statement.org/mod_product/uploads/CONSORT%20Extension%20for%20Non-inferiority%20and%20Equivalence%20Trials%202006.pdf\">[2]</a></span>\n</li>\n<li id=\"cite_note-5\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-5\">^</a></b></span> <span class=\"reference-text\">Zwarenstein M, Treweek S, Gagnier JJ, Altman DG, Tunis S, Haynes B, Oxman AD, Moher D for the CONSORT and Pragmatic Trials in Healthcare (Practihc) group. Improving the reporting of pragmatic trials: an extension of the CONSORT statement. BMJ 2008; 337;a2390. <a rel=\"nofollow\" class=\"external autonumber\" href=\"http://www.consort-statement.org/mod_product/uploads/CONSORT%20Extension%20for%20Pragmatic%20trials%202008.pdf\">[3]</a></span>\n</li>\n<li id=\"cite_note-6\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-6\">^</a></b></span> <span class=\"reference-text\">Ioannidis JP, Evans SJ, Gotzsche PC, O'Neill RT, Altman DG, Schulz K, Moher D. Better reporting of harms in randomized trials: an extension of the CONSORT statement. Ann Intern Med 2004; 141(10):781-788. <a rel=\"nofollow\" class=\"external autonumber\" href=\"http://www.consort-statement.org/mod_product/uploads/CONSORT%20Extension%20for%20Harms%202004.pdf\">[4]</a></span>\n</li>\n<li id=\"cite_note-7\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-7\">^</a></b></span> <span class=\"reference-text\">Hopewell S, Clarke M, Moher D, Wager E, Middleton P, Altman DG, Schulz KF and the CONSORT Group. CONSORT for reporting randomized controlled trials in journal and conference abstracts: explanation and elaboration. PLoS Med 2008 5(1): e20. <a rel=\"nofollow\" class=\"external autonumber\" href=\"http://www.consort-statement.org/mod_product/uploads/CONSORT%20Extension%20for%20Abstracts%202008%20-%20Explanatory%20document.pdf\">[5]</a></span>\n</li>\n<li id=\"cite_note-8\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-8\">^</a></b></span> <span class=\"reference-text\">Gagnier JJ, Boon H, Rochon P, Moher D, Barnes J, Bombardier C. Reporting randomized, controlled trials of herbal interventions: an elaborated CONSORT statement. Ann Intern Med 2006; 144(5):364-367. <a rel=\"nofollow\" class=\"external autonumber\" href=\"http://www.consort-statement.org/mod_product/uploads/CONSORT%20Extension%20for%20Herbal%20Interventions%202006%20(Ann%20Intern%20Med).pdf\">[6]</a></span>\n</li>\n<li id=\"cite_note-9\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-9\">^</a></b></span> <span class=\"reference-text\">Boutron I, Moher D, Altman DG, Schulz K, Ravaud P, for the CONSORT Group. Extending the CONSORT Statement to randomized trials of nonpharmacologic treatment: explanation and elaboration. Ann Intern Med 2008: 148(4):295-309. <a rel=\"nofollow\" class=\"external autonumber\" href=\"http://www.consort-statement.org/mod_product/uploads/CONSORT%20Extension%20for%20Non-Pharmacologic%20Treatements%202008%20-%20Explanatory%20document.pdf\">[7]</a></span>\n</li>\n<li id=\"cite_note-10\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-10\">^</a></b></span> <span class=\"reference-text\">MacPherson H, Altman DG, Hammerschlag R, Youping L, Taixiang W, White A, Moher D; STRICTA Revision Group. Revised STandards for Reporting Interventions in Clinical Trials of Acupuncture (STRICTA): extending the CONSORT statement. PLoS Med. 2010 Jun 8;7(6):e1000261 <a rel=\"nofollow\" class=\"external autonumber\" href=\"http://www.consort-statement.org/mod_product/uploads/3559_STRICTA%20AIM%202010.pdf\">[8]</a></span>\n</li>\n<li id=\"cite_note-11\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-11\">^</a></b></span> <span class=\"reference-text\">The Standards of Reporting Trials Group. A proposal for structured reporting of randomized controlled trials. The Standards of Reporting Trials Group. JAMA. 1994; 272(24):1926-1931.</span>\n</li>\n<li id=\"cite_note-12\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-12\">^</a></b></span> <span class=\"reference-text\">Working Group on Recommendations for Reporting of Clinical Trials in the Biomedical Literature. Call for comments on a proposal to improve reporting of clinical trials in the biomedical literature. Working Group on Recommendations for Reporting of Clinical Trials in the Biomedical Literature. Ann Intern Med. 1994; 121(11):894-895.</span>\n</li>\n<li id=\"cite_note-13\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-13\">^</a></b></span> <span class=\"reference-text\">Rennie D. Reporting randomized controlled trials. An experiment and a call for responses from readers. JAMA 1995; 273(13):1054-1055.</span>\n</li>\n<li id=\"cite_note-14\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-14\">^</a></b></span> <span class=\"reference-text\">Begg C, Cho M, Eastwood S, Horton R, Moher D, <a href=\"/wiki/Ingram_Olkin\" title=\"Ingram Olkin\">Olkin I</a>, Pitkin R, Rennie D, Schulz KF, Simel D, Stroup DF. Improving the quality of reporting of randomized controlled trials: the CONSORT statement. JAMA 1996; 276(8):637-639.</span>\n</li>\n<li id=\"cite_note-15\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-15\">^</a></b></span> <span class=\"reference-text\">Moher D, Schulz KF, Altman DG. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials . Ann Intern Med 2001; 134(8):657-662. <a rel=\"nofollow\" class=\"external autonumber\" href=\"http://www.consort-statement.org/mod_product/uploads/CONSORT%20Statement%202001%20(Ann%20Intern%20Med).pdf\">[9]</a></span>\n</li>\n<li id=\"cite_note-16\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-16\">^</a></b></span> <span class=\"reference-text\">Keech A, Gebski VJ, Pike R. Interpreting and reporting clinical trials. A guide to the CONSORT Statement and the principles of randomised controlled trials. 2007: Australasian Medical Publishing: NSW, Australia.</span>\n</li>\n<li id=\"cite_note-17\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-17\">^</a></b></span> <span class=\"reference-text\">Plint AC, Moher D, Morrison A, Schulz K, Altman DG, Hill C, Gaboury I. Does the CONSORT checklist improve the quality of reports of randomised controlled trials? A systematic review. Med J Aust 2006; 185(5):263-267.</span>\n</li>\n<li id=\"cite_note-18\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-18\">^</a></b></span> <span class=\"reference-text\">Vandenbroucke JP. The making of STROBE. Epidemiology 2007;18: 797e9.</span>\n</li>\n<li id=\"cite_note-19\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-19\">^</a></b></span> <span class=\"reference-text\">Knottnerus JA, Tugwell P. The standards for reporting of diagnostic accuracy. J Clin Epidemiol 2003;56:1118e27</span>\n</li>\n<li id=\"cite_note-20\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-20\">^</a></b></span> <span class=\"reference-text\">Little J, Higgins JPT, Ioannidis JPA, Moher D, Gagnon F, Von Elm E, et al. STrengthening the REporting of Genetic Association studies (STREGA)-an extension of the STROBE Statement. J Clin Epidemiol 2009;62:597e608</span>\n</li>\n<li id=\"cite_note-21\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-21\">^</a></b></span> <span class=\"reference-text\">Liberati A, Altman DG, Tetzlaff J, Mulrow C, G\u00f8tzsche P, et al. and the PRISMA Group (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: Explanation and elaboration. PLoS Med 6: e1000100. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"https://doi.org/10.1371%2Fjournal.pmed.1000100\">10.1371/journal.pmed.1000100</a></span>\n</li>\n<li id=\"cite_note-22\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-22\">^</a></b></span> <span class=\"reference-text\">Davidoff F, Batalden P, Stevens D, Ogrinc G, Mooney S, SQUIRE\nDevelopment Group. Publication guidelines for improvement studies in health care: evolution of the SQUIRE Project. Ann Intern Med 2008;149:670e6</span>\n</li>\n<li id=\"cite_note-23\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-23\">^</a></b></span> <span class=\"reference-text\">Simera I, Altman DG, Moher D, Schulz K, Hoey J. The EQUATOR Network: facilitating transparent and accurate reporting of health research. Serials 2008 Nov 21 (3): 183-87</span>\n</li>\n</ol></div></div>\n\n<!-- \nNewPP limit report\nParsed by mw1343\nCached time: 20180903214012\nCache expiry: 1900800\nDynamic content: false\nCPU time usage: 0.076 seconds\nReal time usage: 0.090 seconds\nPreprocessor visited node count: 393/1000000\nPreprocessor generated node count: 0/1500000\nPost\u2010expand include size: 832/2097152 bytes\nTemplate argument size: 337/2097152 bytes\nHighest expansion depth: 9/40\nExpensive parser function count: 0/500\nUnstrip recursion depth: 0/20\nUnstrip post\u2010expand size: 12426/5000000 bytes\nNumber of Wikibase entities loaded: 0/400\nLua time usage: 0.003/10.000 seconds\nLua memory usage: 523 KB/50 MB\n-->\n<!--\nTransclusion expansion time report (%,ms,calls,template)\n100.00%   44.303      1 Template:Reflist\n100.00%   44.303      1 -total\n 22.63%   10.024      1 Template:DOI\n  7.90%    3.500      2 Template:Hide_in_print\n  5.73%    2.538      1 Template:Only_in_print\n  4.85%    2.149      1 Template:Main_other\n  3.49%    1.545      1 Template:Str_left\n-->\n\n<!-- Saved in parser cache with key enwiki:pcache:idhash:11087233-0!canonical and timestamp 20180903214014 and revision id 857916633\n -->\n</div>"},"langlinks":[{"lang":"fr","url":"https://fr.wikipedia.org/wiki/Consolidated_Standards_of_Reporting_Trials","langname":"French","autonym":"fran\u00e7ais","*":"Consolidated Standards of Reporting Trials"},{"lang":"pl","url":"https://pl.wikipedia.org/wiki/CONSORT","langname":"Polish","autonym":"polski","*":"CONSORT"}],"categories":[{"sortkey":"","*":"Clinical_trials"},{"sortkey":"","*":"Quality_assurance"},{"sortkey":"","*":"Nursing_research"},{"sortkey":"","*":"Reporting_guidelines"}],"links":[{"ns":0,"exists":"","*":"Abstract (summary)"},{"ns":0,"exists":"","*":"Acupuncture"},{"ns":0,"exists":"","*":"British Medical Journal"},{"ns":0,"exists":"","*":"California"},{"ns":0,"exists":"","*":"Checklist"},{"ns":0,"exists":"","*":"Chicago"},{"ns":0,"exists":"","*":"Clinical trial"},{"ns":0,"exists":"","*":"Cluster randomized trial"},{"ns":0,"exists":"","*":"Digital object identifier"},{"ns":0,"exists":"","*":"Doug Altman"},{"ns":0,"exists":"","*":"EQUATOR Network"},{"ns":0,"exists":"","*":"Epidemiology"},{"ns":0,"exists":"","*":"Evidence-based medicine"},{"ns":0,"exists":"","*":"Herbalism"},{"ns":0,"exists":"","*":"Ingram Olkin"},{"ns":0,"exists":"","*":"Journal of the American Medical Association"},{"ns":0,"exists":"","*":"Medical journal"},{"ns":0,"exists":"","*":"Methodology"},{"ns":0,"exists":"","*":"New England Journal of Medicine"},{"ns":0,"exists":"","*":"Ottawa"},{"ns":0,"exists":"","*":"Preferred Reporting Items for Systematic Reviews and Meta-Analyses"},{"ns":0,"exists":"","*":"Randomized controlled trial"},{"ns":0,"exists":"","*":"Strengthening the reporting of observational studies in epidemiology"},{"ns":0,"exists":"","*":"Stuart Pocock"},{"ns":0,"exists":"","*":"Systematic review"},{"ns":0,"exists":"","*":"The Lancet"},{"ns":0,"exists":"","*":"Uniform Requirements for Manuscripts Submitted to Biomedical Journals"}],"templates":[{"ns":10,"exists":"","*":"Template:Reflist"},{"ns":10,"exists":"","*":"Template:DOI"},{"ns":10,"exists":"","*":"Template:Doi"},{"ns":10,"exists":"","*":"Template:Hide in print"},{"ns":10,"exists":"","*":"Template:Str left"},{"ns":10,"exists":"","*":"Template:Only in print"},{"ns":10,"exists":"","*":"Template:Main other"},{"ns":828,"exists":"","*":"Module:Check for unknown parameters"}],"images":[],"externallinks":["http://www.consort-statement.org/mod_product/uploads/CONSORT%20Extension%20for%20Cluster%20Trials%202004.pdf","http://www.consort-statement.org/mod_product/uploads/CONSORT%20Extension%20for%20Non-inferiority%20and%20Equivalence%20Trials%202006.pdf","http://www.consort-statement.org/mod_product/uploads/CONSORT%20Extension%20for%20Pragmatic%20trials%202008.pdf","http://www.consort-statement.org/mod_product/uploads/CONSORT%20Extension%20for%20Harms%202004.pdf","http://www.consort-statement.org/mod_product/uploads/CONSORT%20Extension%20for%20Abstracts%202008%20-%20Explanatory%20document.pdf","http://www.consort-statement.org/mod_product/uploads/CONSORT%20Extension%20for%20Herbal%20Interventions%202006%20(Ann%20Intern%20Med).pdf","http://www.consort-statement.org/mod_product/uploads/CONSORT%20Extension%20for%20Non-Pharmacologic%20Treatements%202008%20-%20Explanatory%20document.pdf","http://www.consort-statement.org/mod_product/uploads/3559_STRICTA%20AIM%202010.pdf","http://www.consort-statement.org/mod_product/uploads/CONSORT%20Statement%202001%20(Ann%20Intern%20Med).pdf","https://doi.org/10.1371%2Fjournal.pmed.1000100"],"sections":[{"toclevel":1,"level":"2","line":"The CONSORT Statement","number":"1","index":"1","fromtitle":"Consolidated_Standards_of_Reporting_Trials","byteoffset":226,"anchor":"The_CONSORT_Statement"},{"toclevel":2,"level":"3","line":"Extensions of the CONSORT Statement","number":"1.1","index":"2","fromtitle":"Consolidated_Standards_of_Reporting_Trials","byteoffset":2113,"anchor":"Extensions_of_the_CONSORT_Statement"},{"toclevel":1,"level":"2","line":"History","number":"2","index":"3","fromtitle":"Consolidated_Standards_of_Reporting_Trials","byteoffset":5463,"anchor":"History"},{"toclevel":1,"level":"2","line":"Impact","number":"3","index":"4","fromtitle":"Consolidated_Standards_of_Reporting_Trials","byteoffset":8562,"anchor":"Impact"},{"toclevel":1,"level":"2","line":"See also","number":"4","index":"5","fromtitle":"Consolidated_Standards_of_Reporting_Trials","byteoffset":11874,"anchor":"See_also"},{"toclevel":1,"level":"2","line":"References","number":"5","index":"6","fromtitle":"Consolidated_Standards_of_Reporting_Trials","byteoffset":11971,"anchor":"References"}],"parsewarnings":[],"displaytitle":"Consolidated Standards of Reporting Trials","iwlinks":[],"properties":[{"name":"wikibase_item","*":"Q2994654"}]}}